REPOCEUTICALS A/S: Financial statements 2020
CVR: 36494433
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -858,803 compared with DKK -523,215 the year before. Equity in the 2020 report amounted to DKK 5,182,914. The solvency ratio was 52.4%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -858,803
- Equity
- DKK 5,182,914
- Total Assets
- DKK 9,885,447
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 0 | -859K | 5.2M | - |
| 2019 | 0 | 0 | -523K | 6M | - |
| 2018 | 0 | 0 | -383K | -356K | - |
| 2017 | - | - | -78K | 27K | - |
| 2016 | - | - | -211K | 105K | - |
Official annual report
How creditworthy is REPOCEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
REPOCEUTICALS A/S has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK -523,215.
As of February 20, 2020, PM Group Holding ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 5%.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.